Formation of the 12q14-q15 amplicon precedes the development of a well-differentiated liposarcoma arising from a nonchondroid pulmonary hamartoma

American Journal of Surgical Pathology

Volumn 30, Issue 10, 2006, Pages 1326-1329

  Trahan, Sylvain ^a   Erickson Johnson, Michele R ^a   Rodriguez, Fausto ^a   Aubry, Marie Christine ^a   Cheville, John C ^a   Myers, Jeffrey L ^a   Oliveira, Andre M ^a  

^a MAYO CLINIC   (United States)

Author keywords

HMGA2; Liposarcoma; MDM2; Pulmonary hamartoma

Indexed keywords

ADULT; AMPLICON; ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME 12Q; CHROMOSOME ANALYSIS; FEMALE; HAMARTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIPOSARCOMA; LUNG TUMOR; TUMOR DIFFERENTIATION;

CHROMOSOMES, HUMAN, PAIR 12; FEMALE; GENE AMPLIFICATION; GENETIC MARKERS; HAMARTOMA; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; LUNG NEOPLASMS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 33748988449     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213257.69478.2f     Document Type: Article

References (15)

1. Basile A, Gregoris A, Antoci B, et al. Malignant change in a benign pulmonary hamartoma. Thorax. 1989;44:232-233.
2. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 1993;68:85-90.
3. Gisselsson D, Hoglund M, Mertens F, et al. Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;23:203-212.
4. Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Clinic Proc. 1996;71:14-20.
5. Kazmierczak B, Rosigkeit J, Wanschura S, et al. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene. 1996;12:515-521.
6. King TC, Myers J. Isolated metastasis to a pulmonary hamartoma. [see comment]. Am J Surgical Pathol. 1995;19:472-475.
7. Oliveira AM, Perez-Atayde AR, Inwards CY, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773-1780.
8. Palvio D, Egeblad K, Paulsen SM. Atypical lipomatous hamartoma of the lung. Virchows Archiv-A, Pathol Anat Histopathol. 1985;405:253-261.
9. Pedeutour F, Forus A, Coindre JM, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer. 1999;24:30-41.
10. Poulsen JT, Jacobsen M, Francis D. Probable malignant transformation of a pulmonary hamartoma. Thorax. 1979;34:557-558.
11. Rossi G, Cavazza A, Valli R, et al. Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax. Lung Cancer. 2003;39:103-106.
12. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet. 2004;155:1-24.
13. Torikata C, Ishiwata K, Fukai S. Malignant change in a solitary hamartoma of the lung. A case report. Acta Pathol Japonica. 1977;27:541-546.
14. World Health Organization (WHO). Tumours of the lung, pleura, thymus and heart. 2004:113-114.
15. van den Bosch JM, Wagenaar SS, Corrin B, et al. Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax. 1987;42:790-793.